20 Aug Health Pemitinib 13.5mg: The Future of FGFR-Focused Cancer Therapies 20/08/2025 By Dipesh Pemitinib 13.5mg is a targeted cancer therapy that contains Pemigatinib, a selective inhibitor of fibroblast growth factor receptors (F...Continue reading